Skip to main content

Table 1 Baseline data of clinical patients. 30 specimens were used in the research. All specimens were divided into two groups dependent of the expression of SLC3A2. In addition, the specimens were also classification of gender, age, pathological stage and grade

From: SLC3A2 inhibits ferroptosis in laryngeal carcinoma via mTOR pathway

  Low_exp High_exp P-value
Total 19 11 /
Gender   Chi square test
 male 10 5 p > 0.05
 female 9 6
Age   p > 0.05
  < 65 6 4
  > =65 13 7
Stage   P = 0.030
 I 8 1
 II 6 1
 III 3 4
 IV 2 5
Grade   P = 0.049
 1 7 1
 2 8 2
 3 2 4
 4 2 4